The global rhinoplasty market accounted for USD 6.29 billion in 2023 and is expected to reach at USD 13.67 billion by 2034 with a CAGR of 7.31% during the forecast period 2024-2034. Rising consciousness regarding aesthetics & personal appearance, increasing introduction of technologically advanced treatment methods such as 3D computer-assisted technologies, growing number of plastic surgery procedures, surge in the utilization of cosmetic surgeries among celebrities, a heightened awareness regarding cosmetic procedures, and growing number of new products being introduced by market players are some of the key factors boosting the market growth.
Rhinoplasty is a surgical intervention aimed at modifying the nasal structure, typically undertaken to address breathing difficulties resulting from injury or congenital structural abnormalities. However, in contemporary practice, it is frequently sought for cosmetic purposes, aiming to refine the nose's shape to improve facial aesthetics or overall physical attractiveness. Hence, increasing launch of new rhinoplasty surgical products by market players is predicted to boost the market growth during the forecast period. For instance, in February 2023, Acclarent, Inc., a division of Johnson & Johnson, has launched the RELIEVE SPINPLUS Balloon Sinuplasty Systems. These systems utilize endoscopic techniques to assist qualified otolaryngologists in expanding obstructed sinus openings and passages in patients with sinusitis and breathing issues. Moreover, they are utilized in nasal reshaping procedures.
By treatment, augmentation was the highest revenue-grossing segment in the global rhinoplasty market in 2023. Silicone implants are increasingly being utilized for nasal reshaping surgery, serving both aesthetic and functional purposes by enhancing the structure and function of the nose. Additionally, revision is predicted to grow at the fastest CAGR during the forecast period owing to the growing incidence of rhinoplasty surgery complications, leading patients to seek secondary nose reshaping procedures to correct deformities resulting from initial rhinoplasty surgeries and increasing introduction of advanced products. For instance, in August 2023, TELA Bio, Inc., a medical technology company with products in commercial use, is dedicated to delivering inventive solutions for soft-tissue reconstruction. Their focus is on achieving optimal clinical results by emphasizing the preservation and restoration of the patient's natural anatomy. The company has introduced the OviTex PRS Long-Term Resorbable product.
By technique, open rhinoplasty was the highest revenue-grossing segment in the global rhinoplasty market in 2023 owing to its capacity to perform intricate & comprehensive nasal surgeries has increased, rise in cosmetic surgical procedures aimed not only at enhancing a person's appearance but also at improving the functionality of the nose. Additionally, closed rhinoplasty is predicted to grow at the fastest CAGR during the forecast period owing to the increasing introduction of innovative products, rising preference for minimally invasive procedures, and growing focus on minimizing post-surgical scarring. Patients often prefer closed nasal surgery for minor adjustments needed in the nose. For instance, in February 2023, Innovia Medical has unveiled its prestigious Summit Medical ENT portfolio in the UK market after a positive reception at the BACO International 2023 event in Birmingham. This range includes the innovative Rhino Rocket and AbsorbENT Nasal and Sinus Packs, praised for their gentle yet effective post-operative compression and exceptional moisture absorption capabilities, facilitating swift healing and easy removal.
By end-user, hospitals was the highest revenue-grossing segment in the global rhinoplasty market in 2023 owing to the surge in number of cosmetic surgical procedures and increasing launch of new products for the rhinoplasty surgical procedures. For instance, in February 2023, Trueaesthetics introduces a non-surgical nose job developed by a plastic surgeon. Additionally, specialty clinics is predicted to grow at the fastest CAGR during the forecast period owing to the increasing inclination towards clinics due to the accessibility of economical surgical treatments.
North America region is anticipated for the highest revenue share during the forecast period owing to a sophisticated healthcare infrastructure, surge in number of certified & proficient cosmetic surgeons, increasing consciousness about aesthetics & appearance, and rising trend of mergers & acquisitions among industry frontrunners. For instance, in February 2023, Athenix, a prominent plastic surgery clinic in the United States, has completed the acquisition of Marina Plastic Surgery and MedSpa, a globally recognized cosmetic surgery center and medical spa situated in Marina Del Rey, California. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the a heightened interest in personal appearance, increase in medical tourism, growing advancements in healthcare infrastructure, rising population of cosmetic surgeons, and surge in trend of market players adopting new business strategies through acquisitions. For instance, in March 2023, Osteopore, a prominent medical device company headquartered in Singapore, has completed the acquisition of several medical distribution enterprises. Collectively, these acquisitions are expected to account for approximately 40% to 45% of global sales for the group. The company anticipates a significant revenue increase, particularly driven by its aesthetic rhinoplasty product line.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Rhinoplasty is a surgical intervention aimed at modifying the nasal structure, typically undertaken to address breathing difficulties resulting from injury or congenital structural abnormalities. However, in contemporary practice, it is frequently sought for cosmetic purposes, aiming to refine the nose's shape to improve facial aesthetics or overall physical attractiveness. Hence, increasing launch of new rhinoplasty surgical products by market players is predicted to boost the market growth during the forecast period. For instance, in February 2023, Acclarent, Inc., a division of Johnson & Johnson, has launched the RELIEVE SPINPLUS Balloon Sinuplasty Systems. These systems utilize endoscopic techniques to assist qualified otolaryngologists in expanding obstructed sinus openings and passages in patients with sinusitis and breathing issues. Moreover, they are utilized in nasal reshaping procedures.
By treatment, augmentation was the highest revenue-grossing segment in the global rhinoplasty market in 2023. Silicone implants are increasingly being utilized for nasal reshaping surgery, serving both aesthetic and functional purposes by enhancing the structure and function of the nose. Additionally, revision is predicted to grow at the fastest CAGR during the forecast period owing to the growing incidence of rhinoplasty surgery complications, leading patients to seek secondary nose reshaping procedures to correct deformities resulting from initial rhinoplasty surgeries and increasing introduction of advanced products. For instance, in August 2023, TELA Bio, Inc., a medical technology company with products in commercial use, is dedicated to delivering inventive solutions for soft-tissue reconstruction. Their focus is on achieving optimal clinical results by emphasizing the preservation and restoration of the patient's natural anatomy. The company has introduced the OviTex PRS Long-Term Resorbable product.
By technique, open rhinoplasty was the highest revenue-grossing segment in the global rhinoplasty market in 2023 owing to its capacity to perform intricate & comprehensive nasal surgeries has increased, rise in cosmetic surgical procedures aimed not only at enhancing a person's appearance but also at improving the functionality of the nose. Additionally, closed rhinoplasty is predicted to grow at the fastest CAGR during the forecast period owing to the increasing introduction of innovative products, rising preference for minimally invasive procedures, and growing focus on minimizing post-surgical scarring. Patients often prefer closed nasal surgery for minor adjustments needed in the nose. For instance, in February 2023, Innovia Medical has unveiled its prestigious Summit Medical ENT portfolio in the UK market after a positive reception at the BACO International 2023 event in Birmingham. This range includes the innovative Rhino Rocket and AbsorbENT Nasal and Sinus Packs, praised for their gentle yet effective post-operative compression and exceptional moisture absorption capabilities, facilitating swift healing and easy removal.
By end-user, hospitals was the highest revenue-grossing segment in the global rhinoplasty market in 2023 owing to the surge in number of cosmetic surgical procedures and increasing launch of new products for the rhinoplasty surgical procedures. For instance, in February 2023, Trueaesthetics introduces a non-surgical nose job developed by a plastic surgeon. Additionally, specialty clinics is predicted to grow at the fastest CAGR during the forecast period owing to the increasing inclination towards clinics due to the accessibility of economical surgical treatments.
North America region is anticipated for the highest revenue share during the forecast period owing to a sophisticated healthcare infrastructure, surge in number of certified & proficient cosmetic surgeons, increasing consciousness about aesthetics & appearance, and rising trend of mergers & acquisitions among industry frontrunners. For instance, in February 2023, Athenix, a prominent plastic surgery clinic in the United States, has completed the acquisition of Marina Plastic Surgery and MedSpa, a globally recognized cosmetic surgery center and medical spa situated in Marina Del Rey, California. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the a heightened interest in personal appearance, increase in medical tourism, growing advancements in healthcare infrastructure, rising population of cosmetic surgeons, and surge in trend of market players adopting new business strategies through acquisitions. For instance, in March 2023, Osteopore, a prominent medical device company headquartered in Singapore, has completed the acquisition of several medical distribution enterprises. Collectively, these acquisitions are expected to account for approximately 40% to 45% of global sales for the group. The company anticipates a significant revenue increase, particularly driven by its aesthetic rhinoplasty product line.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Treatment, Technique, and End-user
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of Top 10+ Major Market Players
Segmentation: Rhinoplasty Market Report 2023 - 2034
Rhinoplasty Market Analysis & Forecast by Treatment 2023 - 2034 (Revenue USD Bn)
- Reconstructive
- Reduction
- Post Traumatic
- Augmentation
- Filler
- Revision
- Others
- Refinement Rhinoplasty
- Ethnic Rhinoplasty
Rhinoplasty Market Analysis & Forecast by Technique 2023 - 2034 (Revenue USD Bn)
- Closed Rhinoplasty
- Open Rhinoplasty
Rhinoplasty Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Others
Rhinoplasty Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Rhinoplasty Market: Treatment Estimates & Trend Analysis
8. Rhinoplasty Market: Technique Estimates & Trend Analysis
9. Rhinoplasty Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Rhinoplasty Market
12. Europe Global Rhinoplasty Market
13. Asia Pacific Global Rhinoplasty Market
14. Latin America Global Rhinoplasty Market
15. MEA Global Rhinoplasty Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Sunset Cosmetic Surgery
- Allergan (Abbvie)
- GC Aesthetics
- Luminera
- Stryker Corporation
- ANTHONY PRODUCTS Inc.
- Implantech
- NOUVAG
- Grover Aesthetics
- Sihuan Pharmaceutical Holdings Group Ltd
- Surgiform Technologies LLC
- SATELEC (Actongroup)
